Home › Liver Cancer (Hepatocellular Carcinoma) › Connecticut › New Haven
Liver Cancer (Hepatocellular Carcinoma) clinical trials in New Haven, CT
6 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #62, New Haven
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RecruitingPhase 3
- Research Site, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Yale University School of Medicine, New Haven
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
RecruitingPhase 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Hamden Care Center, Hamden · 6 mi away
- and 3 more
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Recruiting
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3 mi away
The Dragon PLC Trial (DRAGON-PLC)
Recruiting
- Yale School of Medicine Hospital, New Haven
Liver Cancer (Hepatocellular Carcinoma) trials in other cities
- Houston, TX31 studies
- New York City, NY24 studies
- Dallas, TX19 studies
- Los Angeles, CA19 studies
- Boston, MA18 studies
- Cleveland, OH18 studies
- Chicago, IL16 studies
- Philadelphia, PA16 studies
- Pittsburgh, PA15 studies
- San Francisco, CA14 studies
- Orange, CA14 studies
- Jacksonville, FL14 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.